Published in Br J Rheumatol on February 01, 1994
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
Bronchodilatation after inhalation of the antihistamine clemastine. Thorax (1978) 1.76
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1995) 1.43
Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol (1998) 1.38
Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ (1998) 1.35
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
Translocation of protein kinase C to a Triton-insoluble sub-cellular compartment induced by the lipophilic gold compound auranofin. Biochem Pharmacol (1988) 1.06
Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis (1987) 1.02
Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun (1986) 1.00
Zinc increases phorbol ester receptors in intact B-cells, neutrophil polymorphs and platelets. FEBS Lett (1989) 0.98
Molecular basis of activation and regulation of the phagocyte respiratory burst. Ann Rheum Dis (1987) 0.96
Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. Br Med J (Clin Res Ed) (1981) 0.94
Is chronic renal failure a risk factor for the development of erosive osteoarthritis? Ann Rheum Dis (1989) 0.93
Coxsackie B infection and arthritis. Br Med J (Clin Res Ed) (1983) 0.93
Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochem Pharmacol (1986) 0.92
A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol (1994) 0.86
Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes. Ann Rheum Dis (1983) 0.85
Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1984) 0.84
Wegener's granulomatosis complicated by diabetes insipidus. Ann Rheum Dis (1983) 0.84
Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes. Ann Rheum Dis (1986) 0.84
Inhibition of epidermal growth factor binding to HeLa cells by auranofin. Biochem Pharmacol (1987) 0.83
Calcium ionophore A23187 enhances human neutrophil superoxide release, stimulated by phorbol dibutyrate, by converting phorbol ester receptors from a low- to high-affinity state. FEBS Lett (1987) 0.83
Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations. Rheumatology (Oxford) (2003) 0.82
Quantifying the burden of emotional ill-health amongst patients referred to a specialist rheumatology service. Rheumatology (Oxford) (2003) 0.81
Cervical spine surgery in patients with rheumatoid arthritis: an appraisal. Ann Rheum Dis (1996) 0.81
An audit of methotrexate and folic acid for rheumatoid arthritis. Experience from a teaching centre. Br J Rheumatol (1995) 0.81
Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Biochem Pharmacol (1990) 0.81
Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids. Ann Rheum Dis (1984) 0.81
IgG (kappa) paraproteinaemia and arthritis. Br J Rheumatol (1987) 0.80
Transient presence in serum of an atypical alkaline phosphatase. Clin Chim Acta (1976) 0.78
Effects of piroxicam on superoxide generation, phospholipid methylation and leukotriene production by human blood mononuclear cells. J Rheumatol (1987) 0.78
Inhibition of protein kinase C activity by the antirheumatic drug auranofin. Biochem Pharmacol (1989) 0.78
Enhancement of protein kinase C-mediated EGF receptor phosphorylation by auranofin. Scand J Rheumatol (1988) 0.78
Premature development of erosive osteoarthritis of hands in patients with chronic renal failure. Ann Rheum Dis (1990) 0.77
Re: Quality of life measures. Br J Rheumatol (1997) 0.77
Sjögren's syndrome, vasculitis, and cryoglobulinaemia associated with a monoclonal IgM (kappa) paraprotein with rheumatoid factor activity. Ann Rheum Dis (1987) 0.77
Auranofin increases the affinity of phorbol dibutyrate receptors in chronic lymphocytic leukemia cells (B cells). J Immunol (1987) 0.76
Reactive arthritis--infectious agents and genetic susceptibility in the pathogenesis of sero-negative arthritis. Scott Med J (1983) 0.76
Does economic evaluation have anything to offer the rheumatologist? Rheumatology (Oxford) (1999) 0.76
Re: Measuring outcomes in rheumatoid arthritis--which measures are suitable for routine use? Br J Rheumatol (1997) 0.75
Screening for antimalarial maculopathy in rheumatology clinics. Br Med J (Clin Res Ed) (1985) 0.75
Sclerosing injections in patients with chronic low back pain. Rheumatology (Oxford) (2000) 0.75
Combination therapy in rheumatoid arthritis. Rheumatology (Oxford) (1999) 0.75
Diagnostic criteria for work-related upper limb disorders. Br J Rheumatol (1997) 0.75
Modulation of human neutrophil LTA hydrolase activity by phorbol myristate acetate. Biochem Biophys Res Commun (1987) 0.75
Vasculitis, Raynaud's phenomenon and polyarthritis associated with gemfibrozil therapy. Br J Rheumatol (1993) 0.75
The effects of anti-inflammatory and anti-rheumatic drugs on phagocyte cell function. Agents Actions Suppl (1988) 0.75
Erdheim-Chester disease associated with hydrocalycosis and arthropathy. Arthritis Rheum (1988) 0.75
Destructive spondylarthropathy and chronic renal failure. Arthritis Rheum (1988) 0.75
Calcium ionophore A23187 primes human B-cells for activation by phorbol dibutyrate by converting receptors for phorbol dibutyrate from a low to high affinity state. Biochem Biophys Res Commun (1986) 0.75
Effect of corticosteroid therapy on blood monocyte superoxide generation in rheumatoid arthritis: studies in vitro and ex vivo. Br J Rheumatol (1986) 0.75
Phorbol 12-myristate 13-acetate, A23187 and L-adrenaline inhibit phospholipid methylation in human monocytes and lymphocytes. Inhibition is independent of oxyradical production and phospholipid hydrolysis. Free Radic Biol Med (1990) 0.75
Auranofin enhances phosphorylation of putative substrates of protein kinase C in human platelets. Biochem Pharmacol (1988) 0.75